Lansoprazole Capsule, Delayed Release
Product Images NDC 68788-6390

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 68788-6390). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lansoprazole Delayed Release Capsules 15mg (Container1)

Label for Lansoprazole Delayed-Release Capsules 15 mg by Preferred Pharmaceuticals Inc., generic for Prevacid. The label includes storage instructions, manufacturer Dr. Reddy's Laboratories Limited, and sections for lot, batch, expiration date, and product number. Directions for use are provided in English and Spanish, instructing patients to take the capsules every specified number of hours as directed by a doctor.*

FDA Label Image

Figure1 (Figure1)

A line graph depicting the mean severity of day heartburn by study day for evaluable patients. The y-axis represents the mean severity of heartburn on a scale from 0 (None) to 3 (Severe). The x-axis shows days from the start of treatment, ranging from -5 to 60. Three treatment groups are compared: Placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD, with the Lansoprazole groups showing a notable reduction in heartburn severity over time compared to placebo.*

FDA Label Image

Figure2 (Figure2)

A line graph depicting the mean severity of night heartburn by study day for evaluable patients over a 60-day period. The graph compares three groups: placebo, lansoprazole 15 mg once daily, and lansoprazole 30 mg once daily, showing changes in heartburn severity over time from start of treatment.*

FDA Label Image

Structure (Structure)

Chemical structure of lansoprazole, the active ingredient in the drug Lansoprazole 15 mg delayed-release capsules by Preferred Pharmaceuticals Inc. The structure shows the molecular arrangement of lansoprazole including its benzimidazole and substituted pyridine components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.